Stock A011040 KYUNG DONG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Kyung Dong Pharmaceutical Co., Ltd.

Equities

A011040

KR7011040003

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
6,450 KRW +0.62% Intraday chart for Kyung Dong Pharmaceutical Co., Ltd. +0.47% -2.42%
May. 14 Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 03 Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.
CI
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.
CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 200,000 shares, representing 0.74% for KRW 1,278.39 million.
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 200,000 shares.
CI
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 16, 2022.
CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 16, 202, has closed with 100,000 shares, representing 0.37% for KRW 749.64 million.
CI
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 100,000 shares.
CI
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 17, 2021, has expired.
CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A011040 Stock
  4. News Kyung Dong Pharmaceutical Co., Ltd.
  5. Highlights